CBAY
CymaBay Therapeutics, Inc.
NASDAQHealthcareBiotechnologyUS
Company Profile
CEO
Sujal A. Shah
IPO Date
2014-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
CymaBay Therapeutics, Inc.
CEO
Sujal A. Shah
IPO Date
2014-02-03
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
| 200,000 |
| $5.50 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 100,000 | $11.69 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 138,312 | $8.43 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 328,299 | $4.05 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 66,500 | $5.78 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 175,000 | $2.94 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 215,000 | $7.80 |
| 22 Mar 2024 | Dickinson Klara | Chief Regulatory Officer | D-Return | Disposed | 78,000 | $22.85 |
| 22 Mar 2024 | Shah Sujal | director, officer: Chief Executive Officer | D-Return | Disposed | 96,250 | $32.50 |